Glycyl-Cysteine
Glycyl-Cysteine is a dipeptide composed of glycine and cysteine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Structure for HMDB28838 (Glycyl-Cysteine)
C5H10N2O3S
178.21
178.041212886
2-(2-aminoacetamido)-3-slifanylpropanoic acid
2-(2-aminoacetamido)-3-slifanylpropanoic acid
Not Available
MFBYPDKTAJXHNI-UHFFFAOYSA-N
This compound belongs to the class of chemical entities known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond.
Chemical entities
Organic compounds
Organic acids and derivatives
Carboxylic acids and derivatives
Dipeptides
Aliphatic acyclic compounds
Not Available
Expected but not Quantified
Not Available
Not Available
Not Available
Solid
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
None
None
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
HMDB28838
HMDB28838
Not Available
Not Available
Not Available
Not Available
- Daly TA, Almeida PF, Regen SL: Sorting of lipidated peptides in fluid bilayers: a molecular-level investigation. J Am Chem Soc. 2012 Oct 17;134(41):17245-52. doi: 10.1021/ja3074825. Epub 2012 Oct 4. [PubMed:22998217 ]
- Ferro VA, OGrady JE, Notman J, Stimson WH: Development of a hormone neutralizing vaccine, using GnRH-glycys-PPD, for use in the treatment of oestrogen-dependent disorders. Ther Immunol. 1995 Jun;2(3):147-57. [PubMed:8885133 ]
- Ferro VA, Stimson WH: Effects of adjuvant, dose and carrier pre-sensitisation on the immunisation efficacy of a GnRH analogue. Drug Des Discov. 1996 Dec;14(3):179-95. [PubMed:9017362 ]
- Ferro VA, Stimson WH: Investigation into suitable carrier molecules for use in an anti-gonadotrophin releasing hormone vaccine. Vaccine. 1998 Jul;16(11-12):1095-102. [PubMed:9682364 ]
- Ke Y, Zhao J, Siu KW, Hopkinson AC: Dissociation of copper(II) ternary complexes containing cystine. Phys Chem Chem Phys. 2010 Aug 21;12(31):9017-28. doi: 10.1039/c001908a. Epub 2010 Jun 10. [PubMed:20539872 ]
- Greenfield NJ, Stafford WF, Hitchcock-DeGregori SE: The effect of N-terminal acetylation on the structure of an N-terminal tropomyosin peptide and alpha alpha-tropomyosin. Protein Sci. 1994 Mar;3(3):402-10. [PubMed:8019411 ]
- Ferro VA, Stimson WH: Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer. Eur J Cancer. 1997 Aug;33(9):1468-78. [PubMed:9337691 ]
- Ferro VA, OGrady JE, Notman J, Stimson WH: An investigation into the immunogenicity of a GnRH analogue in male rats: a comparison of the toxicity of various adjuvants used in conjunction with GnRH-glycys. Vaccine. 1996 Apr;14(5):451-7. [PubMed:8735559 ]
- Green DE: The reduction potentials of cysteine, glutathione and glycylcysteine. Biochem J. 1933;27(3):678-89. [PubMed:16745144 ]
- Dringen R, Kranich O, Loschmann PA, Hamprecht B: Use of dipeptides for the synthesis of glutathione by astroglia-rich primary cultures. J Neurochem. 1997 Aug;69(2):868-74. [PubMed:9231749 ]